(Q34088940)

30 July 2017

1 reference

title

The neurobiology, clinical efficacy and safety of acamprosate in the treatment of alcohol dependence (English)

1 reference

30 July 2017

1 reference

1 reference

Barbara J Mason

1

1 reference

30 July 2017

Charles J Heyser

series ordinal

2

1 reference

30 July 2017

language of work or name

English

0 references

publication date

1 January 2010

1 reference

Expert Opinion on Drug Safety

30 July 2017

published in

1 reference

30 July 2017

volume

9

1 reference

30 July 2017

issue

1

1 reference

30 July 2017

page(s)

177-188

1 reference

Pharmacological treatment of alcohol dependence: target symptoms and target mechanisms

30 July 2017

cites work

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Barriers to the use of medications to treat alcoholism.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

A placebo-controlled randomized clinical trial of naltrexone in the context of different levels of psychosocial intervention

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Efficacy and safety of naltrexone and acamprosate in the treatment of alcohol dependence: a systematic review

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Effect of oral acamprosate on abstinence in patients with alcohol dependence in a double-blind, placebo-controlled trial: the role of patient motivation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Neuroprotective and abstinence-promoting effects of acamprosate: elucidating the mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Drug therapy for alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Neurotransmitter and neuromodulatory mechanisms involved in alcohol abuse and alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Neurocircuitry targets in ethanol reward and dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Clinical pharmacokinetics of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Alcohols stimulate gamma-aminobutyric acid receptor-mediated chloride uptake in brain vesicles: correlation with intoxication potency

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol-induced changes in chloride flux are mediated by both GABA(A) and GABA(B) receptors.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol potentiates and blocks NMDA-activated single-channel currents in rat hippocampal pyramidal cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Alcohol potently inhibits the kainate receptor-dependent excitatory drive of hippocampal interneurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Low doses of ethanol activate dopaminergic neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol increases the firing rate of dopamine neurons of the rat ventral tegmental area in vitro

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol and voltage- or receptor-mediated increases in cytosolic Ca2+ in brain cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Alcohol withdrawal reaction as a result of adaptive changes of excitatory amino acid receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Chronic ethanol exposure potentiates NMDA excitotoxicity in cerebral cortical neurons.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Radioligand binding to the N-methyl-D-aspartate receptor/ionophore complex: alterations by ethanol in vitro and by chronic in vivo ethanol ingestion

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Marked decrease of A10 dopamine neuronal firing during ethanol withdrawal syndrome in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Mesolimbic dopaminergic reduction outlasts ethanol withdrawal syndrome: evidence of protracted abstinence.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acute withdrawal after repeated ethanol treatment reduces the number of spontaneously active dopaminergic neurons in the ventral tegmental area

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Chronic ethanol administration alters activity in ventral tegmental area neurons after cessation of withdrawal hyperexcitability

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol regulates calcium channels in clonal neural cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate in alcohol dependence: implications of a unique mechanism of action

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol and amino acids in the central nervous system: assessment of the pharmacological actions of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Mechanism of action of acamprosate. Part I. Characterization of spermidine-sensitive acamprosate binding site in rat brain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Mechanism of action of acamprosate. Part II. Ethanol dependence modifies effects of acamprosate on NMDA receptor binding in membranes from rat cerebral cortex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol withdrawal seizures and the NMDA receptor complex

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

The role of glutamatergic neurotransmission in the pathophysiology of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Markers of glutamatergic neurotransmission and oxidative stress associated with tardive dyskinesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Central effects of acamprosate: part 1. Acamprosate blocks the glutamate increase in the nucleus accumbens microdialysate in ethanol withdrawn rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Potential neuroprotective effects of acamprosate

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Effects of acamprosate on sleep during alcohol withdrawal: A double-blind placebo-controlled polysomnographic study in alcohol-dependent subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

A homotaurine derivative reduces the voluntary intake of ethanol by rats: are cerebral GABA receptors involved?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Chronic acamprosate eliminates the alcohol deprivation effect while having limited effects on baseline responding for ethanol in rats.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

The effects of acamprosate and neramexane on cue-induced reinstatement of ethanol-seeking behavior in rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate decreases the hypermotility during repeated ethanol withdrawal.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate, but not naltrexone, inhibits conditioned abstinence behaviour associated with repeated ethanol administration and exposure to a plus-maze.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate in Korean alcohol-dependent patients: a multi-centre, randomized, double-blind, placebo-controlled study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ability of calcium bis acetyl homotaurine, a GABA agonist, to prevent relapse in weaned alcoholics

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Comparing and combining naltrexone and acamprosate in relapse prevention of alcoholism: a double-blind, placebo-controlled study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Naltrexone versus acamprosate in the treatment of alcohol dependence: A multi-centre, randomized, double-blind, placebo-controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

United Kingdom Multicentre Acamprosate Study (UKMAS): a 6-month prospective study of acamprosate versus placebo in preventing relapse after withdrawal from alcohol.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate during and after acute alcohol withdrawal: a double-blind placebo-controlled study in Spain

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Combined pharmacotherapies and behavioral interventions for alcohol dependence: the COMBINE study: a randomized controlled trial.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate and its efficacy in treating alcohol dependent adolescents

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Meta-analyses of placebo-controlled trials of acamprosate for the treatment of alcohol dependence: impact of the combined pharmacotherapies and behavior interventions study

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

The efficacy of acamprosate in the maintenance of abstinence in alcohol-dependent individuals: results of a meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate supports abstinence, naltrexone prevents excessive drinking: evidence from a meta-analysis with unreported outcomes

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Initiating acamprosate within-detoxification versus post-detoxification in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Does acamprosate improve reduction of drinking as well as aiding abstinence?

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Acamprosate: safety and tolerability in the treatment of alcohol dependence

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

21 January 2018

Sleep of Dry Alcoholics

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Insomnia, self-medication, and relapse to alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Sleep abnormalities during abstinence in alcohol-dependent patients. Aetiology and management.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

The role of postsynaptic calcium in the induction of long-term potentiation

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Intellectual impairment among recently abstinent alcohol abusers.

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Cognitive impairment among alcoholics: impact on drink refusal skill acquisition and treatment outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Implications of cognitive impairment for the treatment of alcoholism

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

A pharmacokinetic and pharmacodynamic drug interaction study of acamprosate and naltrexone

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Alcohol and opioid dependence medications: prescription trends, overall and by physician specialty

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Cost-effectiveness of adjuvant treatment with acamprosate in maintaining abstinence in alcohol dependent patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Development of pharmacotherapies for drug addiction: a Rosetta stone approach

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Ethanol inhibits NMDA-activated ion current in hippocampal neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

Efficacy of Naltrexone and Acamprosate for Alcoholism Treatment: A Meta-Analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1517%2F14740330903512943

10.1517/14740330903512943

21 January 2018

Identifiers

DOI

1 reference

30 July 2017

1 reference